Treating HIV

ViiV Announces Halt to Lersivirine Development

HIV Media Digest - 8 February 2013 - 9:10am

On February 5, 2013, ViiV Healthcare announced that the company has decided to stop the development program investigating its experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) lersivirine.

Treating HIV

Pregnancy does not increase risk of nevirapine side-effects

Aidsmap - 7 February 2013 - 6:10pm

Pregnancy does not increase the risk of nevirapine (Viramune) associated side-effects, according to the results of a systematic review and meta-analysis published in the online edition of AIDS. Investigators found that incidence of liver and skin toxicities – the major side-effects of the drug – were high, but no higher than the rate observed in the

Treating HIV